Experienced Biotech/Pharma CEO, currently CEO Pacylex, CEO Fe Pharmaceuticals, 29yrs in industry; 15 in public companies, 14 in startups. PhD + NIH/NCI.
Fe Pharmaceuticals just published data supporting showing that DIBI, in combination treatment with antibiotics, can suppress resistance to antibiotics. This is a major breakthrough. https://t.co/RJJ4UO5lrl…
#sepsis, #FePharm, #AMR, #ACOA, #antibiotic, #antibioticresistance
Fe Pharmaceuticals just published data supporting showing that DIBI, in combination treatment with antibiotics, can suppress resistance to antibiotics. This is a major breakthrough. https://t.co/IeOECXEeN8
#sepsis, #FePharm, #AMR, #ACOA, #antibiotic, #antibioticresistance
Fe Pharmaceuticals will present "Iron withholding by DIBI sensitizes antibiotic resistant pathogens to diverse antibiotic classes in vitro and in vivo" at World AMR Congress, September 7-8, 2022, Washington DC.#FePharmaceuticals, #AMR, #ACOA, #antibiotic, #antibioticresistance
Delighted to announce the close of a Series A investment in Pacylex Pharmaceuticals. This funds a Phase 1 clinical study, which starts later this month, of a first-in-class small molecule treatment in Lymphoma and solid tumor patients. https://t.co/iQBb5xEkuV
PCLX-001 selectively kills cancer cells while sparing normal cells, “the holy grail of cancer therapy". https://t.co/YQYOnm7xRP #AML#cancer@kerisweetman@albertacancer
Chelation Partners was named an Impact startup for the Global technology Collision Conference, April 20-22, 2021. Collision is a massive annual startup conference.
Chelation Partners is also a featured startup in MedTech and Pharma. #COVID19#sepsis#ChelationPartners#AMR
#Oilers alum Kyle Brodziak still out there GRINDING in The World's Longest Hockey Game in support of the Cure Cancer Foundation!
You can help them get over the fundraising goal finish line by visiting https://t.co/x475KUmTFi.
@NHLAlumni | 🧡💙
Pacylex extending proof-of-concept for NMT inhibitors as potential cancer therapeutics for blood cancers https://t.co/OVNhNbBex0 #oncology#lymphoma#NMT#inhibitor#cancer
Results show that by day 6, NMT inhibitor PCLX-001 effectively kills nearly all types of cancer cell lines tested. https://t.co/pwdmtgww7C #oncology#lymphoma#NMT#inhibitor#cancer